{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:11:19Z","timestamp":1767139879229,"version":"build-2238731810"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00535-015-1056-1","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T22:40:41Z","timestamp":1425422441000},"page":"1069-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A thymine\u2013adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus"],"prefix":"10.1007","volume":"50","author":[{"given":"Satoshi","family":"Hiramine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Furusyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Korenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1286-4579(02)01649-0","volume":"4","author":"W Ray Kim","year":"2002","unstructured":"Ray Kim W. Global epidemiology and burden of hepatitis C. Microbes Infect. 2002;4:1219\u201325.","journal-title":"Microbes Infect"},{"key":"1056_CR2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","volume":"36","author":"LB Seeff","year":"2002","unstructured":"Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36:S35\u201346.","journal-title":"Hepatology"},{"key":"1056_CR3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975\u201382.","journal-title":"N Engl J Med"},{"key":"1056_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958\u201365.","journal-title":"Lancet"},{"key":"1056_CR5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1440-1746.2008.05319.x","volume":"23","author":"N Furusyo","year":"2008","unstructured":"Furusyo N, Kajiwara E, Takahashi K, et al. Association between the treatment length and cumulative dose of PEGylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group. J Gastroenterol Hepatol. 2008;23:1094\u2013104.","journal-title":"J Gastroenterol Hepatol"},{"key":"1056_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399\u2013401.","journal-title":"Nature"},{"key":"1056_CR7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41:1100\u20134.","journal-title":"Nat Genet"},{"key":"1056_CR8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to PEGylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105\u20139.","journal-title":"Nat Genet"},{"key":"1056_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4:69\u201377.","journal-title":"Nat Immunol"},{"key":"1056_CR10","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","volume":"131","author":"T Marcello","year":"2006","unstructured":"Marcello T, Grakoui A, Barba-Spaeth G, et al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology. 2006;131:1887\u201398.","journal-title":"Gastroenterology"},{"key":"1056_CR11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798\u2013801.","journal-title":"Nature"},{"key":"1056_CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2893.2011.01497.x","volume":"19","author":"HY Rao","year":"2012","unstructured":"Rao HY, Sun DG, Jiang D, et al. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection. J Viral Hepat. 2012;19:173\u201381.","journal-title":"J Viral Hepat"},{"key":"1056_CR13","doi-asserted-by":"crossref","first-page":"e26620","DOI":"10.1371\/journal.pone.0026620","volume":"6","author":"M Sugiyama","year":"2011","unstructured":"Sugiyama M, Tanaka Y, Wakita T, et al. Genetic variation of the IL-28B promoter affecting gene expression. PLoS One. 2011;6:e26620.","journal-title":"PLoS One"},{"key":"1056_CR14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/323890","volume":"184","author":"Y Kishihara","year":"2001","unstructured":"Kishihara Y, Furusyo N, Kashiwagi K, et al. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J Infect Dis. 2001;184:1114\u20139.","journal-title":"J Infect Dis"},{"key":"1056_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/hep.23002","volume":"50","author":"H Uto","year":"2009","unstructured":"Uto H, Stuver SO, Hayashi K, et al. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology. 2009;50:393\u20139.","journal-title":"Hepatology"},{"key":"1056_CR16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jmv.10448","volume":"71","author":"H Watanabe","year":"2003","unstructured":"Watanabe H, Saito T, Shinzawa H, et al. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol. 2003;71:56\u201361.","journal-title":"J Med Virol"},{"key":"1056_CR17","first-page":"75","volume":"109","author":"D Vlahov","year":"1991","unstructured":"Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75\u2013100.","journal-title":"NIDA Res Monogr"},{"key":"1056_CR18","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/JCM.02139-10","volume":"49","author":"K Ito","year":"2011","unstructured":"Ito K, Higami K, Masaki N, et al. The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to PEGylated alpha interferon\/ribavirin therapy in Japanese patients than other single-nucleotide polymorphisms associated with interleukin-28B. J Clin Microbiol. 2011;49:1853\u201360.","journal-title":"J Clin Microbiol"},{"key":"1056_CR19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/7044","volume":"17","author":"V Lyamichev","year":"1999","unstructured":"Lyamichev V, Mast AL, Hall JG, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol. 1999;17:292\u20136.","journal-title":"Nat Biotechnol"},{"key":"1056_CR20","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1021\/bi0007829","volume":"39","author":"VI Lyamichev","year":"2000","unstructured":"Lyamichev VI, Kaiser MW, Lyamicheva NE, et al. Experimental and theoretical analysis of the invasive signal amplification reaction. Biochemistry. 2000;39:9523\u201332.","journal-title":"Biochemistry"},{"key":"1056_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2188\/jea.6.1","volume":"6","author":"M Ishibashi","year":"1996","unstructured":"Ishibashi M, Shinzawa H, Kuboki M, et al. Prevalence of inhabitants with anti-hepatitis C virus antibody in an area following an acute hepatitis C epidemic: age-and area-related features. J Epidemiol. 1996;6:1\u20137.","journal-title":"J Epidemiol"},{"key":"1056_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.hepres.2005.10.004","volume":"34","author":"H Uto","year":"2006","unstructured":"Uto H, Hayashi K, Kusumoto K, et al. Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan. Hepatol Res. 2006;34:28\u201334.","journal-title":"Hepatol Res"},{"key":"1056_CR23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","volume":"284","author":"DL Thomas","year":"2000","unstructured":"Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450\u20136.","journal-title":"JAMA"},{"key":"1056_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-132-2-200001180-00003","volume":"132","author":"LB Seeff","year":"2000","unstructured":"Seeff LB, Miller RN, Rabkin CS, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med. 2000;132:105\u201311.","journal-title":"Ann Intern Med"},{"key":"1056_CR25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0168-8278(00)80268-8","volume":"33","author":"MT Raijmakers","year":"2000","unstructured":"Raijmakers MT, Jansen PL, Steegers EA, et al. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol. 2000;33:348\u201351.","journal-title":"J Hepatol"},{"key":"1056_CR26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/jhep.2000.18193","volume":"32","author":"J Borlak","year":"2000","unstructured":"Borlak J, Thum T, Landt O, et al. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert\u2019s syndrome) in healthy subjects. Hepatology. 2000;32:792\u20135.","journal-title":"Hepatology"},{"key":"1056_CR27","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","volume":"95","author":"E Beutler","year":"1998","unstructured":"Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA. 1998;95:8170\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1056_CR28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1469-1809.2010.00638.x","volume":"75","author":"LJ Horsfall","year":"2011","unstructured":"Horsfall LJ, Zeitlyn D, Tarekegn A, et al. Prevalence of clinically relevant UGT1A alleles and haplotypes in African populations. Ann Hum Genet. 2011;75:236\u201346.","journal-title":"Ann Hum Genet"},{"key":"1056_CR29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1055-9965.EPI-07-2517","volume":"17","author":"TO Lankisch","year":"2008","unstructured":"Lankisch TO, Schulz C, Zwingers T, et al. Gilbert\u2019s syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer Epidemiol Biomarkers Prev. 2008;17:695\u2013701.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1056_CR30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","volume":"340","author":"E Kenny-Walsh","year":"1999","unstructured":"Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med. 1999;340:1228\u201333.","journal-title":"N Engl J Med"},{"key":"1056_CR31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1872-034X.2010.00671.x","volume":"40","author":"Y Tanaka","year":"2010","unstructured":"Tanaka Y, Nishida N, Sugiyama M, et al. lambda-Interferons and the single-nucleotide polymorphisms: a milestone to tailor-made therapy for chronic hepatitis C. Hepatol Res. 2010;40:449\u201360.","journal-title":"Hepatol Res"}],"updated-by":[{"DOI":"10.1007\/s00535-015-1155-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,12,25]],"date-time":"2015-12-25T00:00:00Z","timestamp":1451001600000}}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-015-1056-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1056-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:40:15Z","timestamp":1559083215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-015-1056-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s00535-015-1056-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,5]]}}}